Oral Oncology
Volume 45, Issue 12 , Pages 1037-1043 , December 2009

Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals

  • Dongmei Ma

      Affiliations

    • Molecular Cellular Physiology, Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
    • ,
  • Eiji Warabi

      Affiliations

    • Molecular Cellular Physiology, Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
    • ,
  • Toru Yanagawa

      Affiliations

    • Oral and Maxillofacial Surgery, Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki 305-8575, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 29 853 3052; fax: +81 29 853 3052.
    • ,
  • Shintaro Kimura

      Affiliations

    • Molecular Cellular Physiology, Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
    • ,
  • Harumi Harada

      Affiliations

    • Molecular Cellular Physiology, Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
    • ,
  • Kenji Yamagata

      Affiliations

    • Oral and Maxillofacial Surgery, Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki 305-8575, Japan
    • ,
  • Tetsuro Ishii

      Affiliations

    • Molecular Cellular Physiology, Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan

Received 1 May 2009 ,Revised 1 July 2009 ,Accepted 2 July 2009.

References 

  1. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003;1:47–61
  2. Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep. 2004;11(3):559–595
  3. Lamont EB, Vokes EE. Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol. 2001;2(5):261–269
  4. Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, Guttenplan J. Cisplatin nephrotoxicity. Am J Kidney Dis. 1986;8(5):356–367
  5. Ueda N, Kaushal GP, Shah SV. Apoptotic mechanisms in acute renal failure. Am J Med. 2000;108(5):403–415
  6. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem. 1994;269(44):27670–27678
  7. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52(1–2):35–41
  8. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem. 2002;383(3–4):347–364
  9. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003;28(1):32–40
  10. Uwayama J, Hirayama A, Yanagawa T, Warabi E, Sugimoto R, Itoh K, et al. Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals. Biochem Biophys Res Commun. 2006;339(1):226–231
  11. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986;94(1–2):57–63
  12. Ishii T, Yamada M, Sato H, Matsue M, Taketani S, Nakayama K, et al. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J Biol Chem. 1993;268(25):18633–18636
  13. Brozovic A, Osmak M. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett. 2007;251(1):1–16
  14. Ishii T, Yanagawa T. Stress-induced peroxiredoxins. Subcell Biochem. 2007;44:375–384
  15. Jacobson FS, Morgan RW, Christman MF, Ames BN. An alkyl hydroperoxide reductase from Salmonella typhimurium involved in the defense of DNA against oxidative damage. Purification and properties. J Biol Chem. 1989;264(3):1488–1496
  16. Poole LB, Ellis HR. Flavin-dependent alkyl hydroperoxide reductase from Salmonella typhimurium. 1. Purification and enzymatic activities of overexpressed AhpF and AhpC proteins. Biochemistry. 1996;35(1):56–64
  17. Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature. 2000;407(6801):211–215
  18. Peshenko IV, Shichi H. Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic Biol Med. 2001;31(3):292–303
  19. Wen ST, Van Etten RA. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 1997;11(19):2456–2467
  20. Li B, Wang X, Rasheed N, Hu Y, Boast S, Ishii T, et al. Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. Genes Dev. 2004;18(15):1824–1837
  21. Van Etten RA. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 1999;9(5):179–186
  22. Sun X, Wu F, Datta R, Kharbanda S, Kufe D. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem. 2000;275(11):7470–7473
  23. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 1997;387(6632):516–519
  24. Kharbanda S, Pandey P, Yamauchi T, Kumar S, Kaneki M, Kumar V, et al. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol Cell Biol. 2000;20(14):4979–4989
  25. Masutani H, Ueda S, Yodoi J. The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ. 2005;12(Suppl 1):991–998
  26. Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, et al. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene. 1999;18(1):173–180
  27. Kim SY, Kim TJ, Lee KY. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett. 2008;582(13):1913–1918
  28. Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther. 2006;319(3):991–997

PII: S1368-8375(09)00845-8

doi: 10.1016/j.oraloncology.2009.07.002

Oral Oncology
Volume 45, Issue 12 , Pages 1037-1043 , December 2009

Article Tools

* Image Usage & Resolution